Omabit is an AI platform for life science R&D that analyzes preclinical, clinical data and writes reports for pharma and biotech teams.
Omabit has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in October 2026.
Omabit's investors include Bright Ventures Leadership Accelerator.
Omabit is headquartered in San Francisco, United States.
Omabit is an AI platform for life science R&D that analyzes preclinical, clinical data and writes reports for pharma and biotech teams.
Omabit is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Omabit — Funding & Investors." VCBacked, October 26, 2026, https://www.vcbacked.co/company/omabit. Accessed November 2, 2026.
VCBacked. (2026). Omabit — Funding & Investors. Retrieved November 2, 2026, from https://www.vcbacked.co/company/omabit
{{cite web |title=Omabit — Funding & Investors |url=https://www.vcbacked.co/company/omabit |website=VCBacked |access-date=November 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Omabit? Request a listing update